License our intellectual property - The University of Sydney
Researcher working with a microscope

License our intellectual property

Bring our innovations to market
We have a large portfolio of inventions available for licensing, commercialisation and investment.

Our portfolio of inventions and innovations spans a number of sectors, including diagnostics, therapeutics, biomedical devices and optical technology.

Download a summary of our available opportunities in therapies, diagnostics and medical devices for partnering (pdf, 4.1MB)

Transform pioneering research into impactful innovations through licensing, collaboration, and investment opportunities. Contact the Commercialisation Office

Licensing Opportunities


Life sciences

A new gene editing technology that offers enhanced precision and the capability to insert large DNA sequences without off-target mutations or triggering error-prone DNA repair. Using SeekRNA as a new gene editing technology (pdf, 216.7KB)

Inventors: Sandro F Ataide, Rezwan Siddiquee, Ruth Hall   

Contact: taylor.syme@sydney.edu.au

Novel inhibitors that target the two-partner secretion system, potentially blocking the secretion of virulence factors in Gram-negative bacteria, offering a new approach to combat bacterial infections. Two-partner secretion system inhibitors (pdf, 150.6KB)

Inventors: Matthew Thomas Doyle, Alfred Hartojo, Peggy Cotter, Richard Johnson 

Contact: taylor.syme@sydney.edu.au 

Blood biomarker panel for the early detection of pancreatic cancer. 

Inventors: Sumit Sahni, Anubhav Mittal, Jaswinder Samra, Mark Molloy, Bharat Venkatesh Gundappa, Matthew J Mckay, Sooin Byeon 

Contact: taylor.syme@sydney.edu.au 

An antibody targeting Myc, with the potential to disrupt this otherwise "undruggable" target in various cancers. Antibody targeting Myc (pdf, 189.2KB)

Contact: taylor.syme@sydney.edu.au 

A molecular diagnostic solution with over 95% specificity, leveraging DNA sequencing to objectively differentiate melanoma from benign naevi, thereby reducing the subjectivity and variability of traditional histopathology. MIAdx Molecular Diagnostic Test of Melanocytic lesions (pdf, 203.1KB)

Inventors: Richard A. Scolyer, Georgina Long, Ismael A. V. Correa, Andrew Colebatch, James Wilmott

Contact: taylor.syme@sydney.edu.au

A PSA-activated peptide sequence for prodrugs that enables targeted therapy for prostate cancer. A new approach for precision therapy for prostate cancer (pdf, 124.7KB).

Inventors: Trevor Hambley, Elisabeth Tondl

Contact: emma-louise.hunsley@sydney.edu.au

This invention is a new image reconstruction method for new generation linear accelerators that use rapid CBCT acquisition protocols. Reduction of motion artefacts for 4DCBCT (pdf, 95.3KB)

Inventors: Dr Mark Gardner, Dr Owen Thomas Dillon, Professor Paul Keall, Dr Hilary Byrne

Contact: emma-louise.hunsley@sydney.edu.au  

This invention is a new copper-sensing molecular probe with applications for early diagnosis of Parkinson’s disease and management of amyotrophic lateral sclerosis. A biomedical device for precision imaging of copper levels in the CNS (pdf, 78.9KB)

Inventors: Professor Elizabeth New, Professor Kay Double, Marcus Graziotto, Dr Liam Adair

Contact: julius.juarez@sydney.edu.au   

This invention is an antivenom treatment offering a broad-spectrum solution for neutralising toxins from various sources including snakes and marine life. A new broad acting antidote for venom-induced local dermal necrosis (pdf, 20.9KB)

Inventors: Professor Graham Neely, Felicity Shu Yin Chung, Nicholas Casewell, Tian Du

Contact: julius.juarez@sydney.edu.au  

This invention is a protein-based bioglue formulated to bind to neuronal tissues. Bio glue for high-precision repair of neuronal tissue (pdf, 29.2KB)

Inventors: Dr Jingjing You, Jiawen Fan, Professor Matthew Simunovic, Professor Gerard Sutton, Dr Sheng Hua

Contact: julius.juarez@sydney.edu.au

A series of new ligands that exhibit significantly higher affinity for a biomarker of neuroinflammation. High accuracy agents for imaging neuroinflammation (pdf, 81.1KB)

Inventors: Dr Jonathan Danon, Professor Michael Kassiou, Greta Sohler, Dr Renee Sokias, Dr Tristan Reekie, Dr Eryn Werry

Contact: julius.juarez@sydney.edu.au  

This invention relates to new phage-drug nanoconjugates for combating bacterial infections. Innovative phage-drug nanoconjugates to combat antimicrobial resistance (pdf, 47.1KB)

Inventors: Professor Jonathan Iredell, Dr Hien Thi Duong, Huiping Huang

Contact: julius.juarez@sydney.edu.au

A novel phage extracellular vesicle (EV) conjugate designed to promote tissue repair in individuals with bacterial infections. Novel bioactive nano-constructs for treatment of chronic wound infections (pdf, 21.4KB)

Inventors: Professor Wojciech Chrzanowski, Dr Hien Thi Duong

Contact: julius.juarez@sydney.edu.au

This invention relates to peptide mimetic compounds, inspired by the natural healing capabilities of PDGF but engineered to circumvent the pitfalls of prolonged exposure that can lead to fibrosis. Novel peptide mimetic for heart repair (pdf, 30.2KB)

Inventors: A/Professor James Chong, Emily McKinna, Professor Richard James Payne, Daniel Ford, Richard Harvey, Dr Osvaldo Contreras

Contact: julius.juarez@sydney.edu.au

A novel system designed to harness the power of directed evolution within mammalian cells. Novel system for directed evolution in mammalian cells (pdf, 73.1KB)

Inventors: Dr Daniel Hesselson, Professor Graham Gregory Neely, Dr Alexander Cole, Christopher Denes

Contact: julius.juarez@sydney.edu.au

This is a targeted TNBC therapy formed of an antineoplastic agent and an LHRH (Leuteinising hormone release hormone) peptide derivative which has been conjugated to an anti-mitotic agent. Receptor targeted therapy for triple negative breast cancer (pdf, 112.4KB)

Inventors: Dr Pegah Varamini and Sepideh Khazeni.

Contact: julius.juarez@sydney.edu.au

The innovation at hand is a nanoparticle bioconjugate that employs a dual-nanoparticle approach to target and bind to both cancer cells and immune cells. Targeted cancer therapy using bispecific nanoconjugates (pdf, 73.4KB)

Inventors: A/Professor Veysel Kayser, Mariam Tarkistani.

Contact: julius.juarez@sydney.edu.au

During chemotherapy this sensor monitors platinum complex levels for a more effective adjustment of dosages, and patient treatment plans with few side-effects. Fluorescent sensor for detection of multiple anticancer complexes (pdf, 135KB)

Inventors: Elizabeth New, Linda Mitchell, and Clara Shen.

Contact: julius.juarez@sydney.edu.au

A targeted TNBC (Triple Negative Breast Cancer) therapy with increased selectivity and efficacy and decreased toxicity. Receptor targeted delivery for antineoplastic agents to breast cancer cells (pdf, 152KB)

Inventors:
Pegah Varamini and Sepideh Khazeni

Contact: julius.juarez@sydney.edu.au

A non-invasive device that measures multiple medical signs continuously which can be applied to blood pressure monitors, pulse oximeters, activity & fitness trackers, sleep oxygen monitors, heartrate monitors. Self-training continuous blood pressure monitor (pdf, 71.3KB)

Inventors: Simon Poon and Anusha Withana

Contact: julius.juarez@sydney.edu.au

A board game to educate future clinicians about how different members of rural communities interact with the Australian Healthcare system. The Australian Rural Health Game (pdf, 339.3KB)

Inventors: Heather Russell, Christopher Harrison, Lisa Hampshire, Marguerite Tracy, Annette Burgess, Matthew Tyne, Jayne Crew, Alice Henschke, Catherine Hawke

Contact: emma-louise.hunsley@sydney.edu.au

A number of novel transcription factors associated with functional CAR-T cell phenotypes and proliferation, and methods of identifying more. Augmenting cell therapy to improve efficacy (pdf, 107KB)

Inventors: Salvatore Fiorenza, Cameron Turtle
Contact: emma-louise.hunsley@sydney.edu.au

A novel software capable of tracking the movement of multiple targets during radiation therapy. Radiotherapy targeting software for more accurate prostate cancer treatment (pdf, 102.1KB)

Inventors: Emily Hewson, Paul Keall, Owen Thomas Dillon, Jeremy Booth

Contact: emma-louise.hunsley@sydney.edu.au

A novel software capable of predicting 3D lung motion with only 10 x-ray projections, for large scale lung disease screening. Low dose ventilation imaging software for lung disease screening (pdf, 118.8KB)

Inventors: Paul Keall, Hunor Kertesz, Owen Dillon, Hilary Byrne, Ricky O'Brien

Contact: emma-louise.hunsley@sydney.edu.au

A novel software to increase CT image quality thereby improving accuracy and decreasing patient radiation dose. High quality, real time CT imaging software (REACT) (pdf, 141.2KB)

Inventors: Natasha Morton, Ricky Thomas O'Brien, Paul Keall, Jeffrey Barber, Jonathan Sykes, John Kipritidis

Contact: emma-louise.hunsley@sydney.edu.au

Multispectral analysis of urinary biomarkers to non-invasively identify acute tubular necrosis, graft rejection and non-rejection associated interstitial fibrosis and tubular atrophy. Diagnostic for kidney transplant graft dysfunction (pdf, 150KB)

Inventors: Sonia Saad, Caroll Pollock, Ewa Goldys, Hon Lin Henry Wu, Yandong Lang

Contact: emma-louise.hunsley@sydney.edu.au

A small device designed to mimic the appearance of hair, capable of interfacing with the brain for sensing, actuation and as a delivery mechanism. Artificial hair as a brain interface (pdf, 130.7KB)

Inventors: Omid Kavehei

Contact: emma-louise.hunsley@sydney.edu.au

Plasma treatment to enable cell growth within a microfluidic device for greater accuracy. Improving organ on a chip technology (pdf, 101.4KB)

Inventors: Marcela Bilek, Jasneil Singh, Anna Waterhouse, Deepu Ashok, Shouyuan Jiang

Contact: emma-louise.hunsley@sydney.edu.au

Physical sciences

Fibre sensors made of this low YM material will improve existing uses of OFS technology and open new opportunities in smart textiles, wearables, implantable therapeutic devices health care and soft robotics. Stretchable optical fibre (pdf, 156.4KB)

Inventors: Prof Simon Fleming, Dr Richard Lwin, Dr Alessio Stefani, and Dr Md Rejvi Kaysir

Contact: jeremy.cohen@sydney.edu.au

A significant advance in recycling with opportunities in areas including recycled composites for automotive, aerospace, sporting equipment, mining and defence parts, construction materials, 3D printing filaments, and consumer products. Closed-loop recycling of fibre-reinforced plastic composites (pdf, 167.9KB)

Inventor: Dr Ali Hadigheh

Contact: lulu.xue@sydney.edu.au

A technology that adds low cost and simple architecture to the existing advantages of photonics-based radar. Low-frequency photonics-based broadband radar imaging and sensing (36KB)

Inventors: Dr Yang Liu, Mr Ziqian Zhang, Professor Benjamin Eggleton.

Contact: jeremy.cohen@sydney.edu.au

Customising the shells, the nanoparticles’ magnetic properties can be tailored to suit specific applications biomedicine, electronics, and sustainable and renewable energy. Multi-shell magnetic nanoparticles (pdf, 190KB)

Inventors: Prof. Hala Zreiqat AM & Dr Gurvinder Singh

Contact: lulu.xue@sydney.edu.au

 

A compact wearable ECG monitoring device employing AI-based deep learning algorithms for accurate, real-time diagnosis of cardiac arrhythmia. Wearable ECG monitoring system (pdf, 70.6KB)

Inventors: Prof. Branka Vucetic, A/Prof. Zihuai Lin, and Xucun Yan

Contact:
 lulu.xue@sydney.edu.au

 

 

 

An improved protein coating process that enables covalent attachment of any protein to a glass surface without using chemical linkers or any additional reagents which could drive a growth in the global medica coatings market. Transparent plasma-activated coated glass substrates (pdf, 139.6KB)

Inventors: Prof. Marcela Bilek, Dr. Clara Thao Hoang Tran, Dr. Stuart Tallis Fraser, Dr. Badwi Bob Boumelhem, and Dr. Aaron Gilmour

Contact: lulu.xue@sydney.edu.au

An on-chip real-time versatile sensing system that can be applied to many in-situ and off-line measurement scenarios including electric vehicle battery monitoring, blood tests and nanoparticles sensing. Microwave photonic multiparameter sensing (pdf, 104.1KB)

Inventors: Prof. Xiaoke Yi, Dr Xiaoyi Tian

Contact: lulu.xue@sydney.edu.au

A revolutionary technology to help those grappling with complex communication needs. Wearable augmentative and alternative communication (wAAC) (pdf, 76.2KB)

Inventors: Prof. Alistair McEwan, Prof. Petra Karlsson, Haifeng Zha

Contact: lulu.xue@sydney.edu.au

Other

A framework designed to support emergency nurses in assessing and managing emergency department patients after triage. HIRAID training materials (149.9KB)

Inventors: Belinda Kennedy, Julie Considine, Kate Curtis, John Mackenzie, Margaret Murphy, Sarah Kourouche, Margaret Fry, Ramon Shaban

Contact: taylor.syme@sydney.edu.au

A custom-designed web-based platform for automating the administration of the Indigenous Tutorial Assistance Scheme-Tertiary Tuition (ITAS-TT) ITAS platform (pdf, 104.3KB)

Creators: Designed at the University of Sydney by the Office of the DVC (Indigenous Strategy and Services) and developed by TechLab in Information and Communication Technology (ICT)

Contact: taylor.syme@sydney.edu.au


Success stories

We're affiliated with a number of startups and new venture projects that have spun out from our technologies. 

Our ventures

Kinoxis Therapeutics Pty Ltd was spun out of the University of Sydney in 2018 and has since raised more than $10M to develop its novel anti-addiction drugs for use in the treatment of substance use disorders and other central nervous system disorders. 

The spin off follows years of research led by Professor Iain McGregor, which was the first to show oxytocin administration to laboratory animals causes long-term increases in sociability and a lasting decrease in alcohol and methamphetamine self-administration.

Read more about this research.

Elastagen Pty Ltd is a clinical-stage medical device company that is pioneering Elastatherapy, which uses the human protein elastin to naturally repair and augment the skin.

The company has arisen out of patented research conducted by Professor Tony Weiss’s group and the first clinical trials have demonstrated the biocompatibility and safety of their synthetic human elastin in human subjects. 

Elastagen was aquired by leading global biopharmaceutical company, Allergan, in 2018.

Partner with us - Healthtech licensing opportunities

4.1MB
Download PDF

Find a researcher

Search by name, area of expertise or faculty